Thiazolidinedione → 3-(Imidazo[1,2-a]pyridin-5-yl)methylthiazolidine-2,4-dione
Reaktionsgleichung
O[CH2:2][C:3]1[N:8]2[CH:9]=[CH:10][N:11]=[C:7]2[CH:6]=[CH:5][CH:4]=1.S(Cl)(Cl)=O.[S:16]1[CH2:20][C:19](=[O:21])[NH:18][C:17]1=[O:22].C1CCN2C(=NCCC2)CC1>ClCCl.CN(C)C=O.O>[N:11]1[CH:10]=[CH:9][N:8]2[C:3]([CH2:2][N:18]3[C:19](=[O:21])[CH2:20][S:16][C:17]3=[O:22])=[CH:4][CH:5]=[CH:6][C:7]=12Komponenten
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 3
Versuchsvorschrift
To a suspension of 1.19 g (8.0 mmol) of 5-hydroxymethylimidazo[1,2-a]pyridine in 10 ml of dichloromethane, 4.05 ml (56 mmol) of thionyl chloride was added, followed by stirring at room temperature for 1 hour, after which the solvent was distilled off. To a solution of this residue and 0.94 g (8.0 mmol) of thiazolidine-2,4-dione in 15 ml of N,N-dimethylformamide, 2.40 ml (16.0 mmol) of 1,8-diazabicyclo[5.4.0]-7-undecene was added, followed by stirring at 80° C. for 16 hours. After the reaction mixture was cooled, water was added; the mixture was extracted with ethyl acetate and dried, after which the solvent was distilled off. The residue was purified by recrystallization (solvent, chloroform/ethyl acetate/diethyl ether) to yield 247 mg (12.5%, light brown powder) of the desired product.
Aufarbeitung
- additionwas added
- distillationafter which the solvent was distilled off
- stirringby stirring at 80° C. for 16 hours
- temperatureAfter the reaction mixture was cooled
- extractionthe mixture was extracted with ethyl acetate
- customdried
- distillationafter which the solvent was distilled off
- customThe residue was purified by recrystallization (solvent, chloroform/ethyl acetate/diethyl ether)
Quellen und Nachweise
- ORD-Eintrag
- ord-1dfb89d2f3a24e2b8e365cbaa6dc03eb
- Quelldatensatz
- uspto-grants-1998_11
- Patentnummer
- US05840732
Notizen zur Reaktion
Wird geladen…